Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
633.8 INR | -0.07% |
|
+4.31% | -2.06% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- Sales forecast by analysts have been recently revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- Low profitability weakens the company.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 72.42 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.06% | 16.34B | B- | ||
+10.87% | 99.05B | B- | ||
+4.07% | 95.65B | B | ||
+27.21% | 80.1B | D+ | ||
-18.66% | 76.93B | B+ | ||
+42.59% | 37.06B | A | ||
+31.28% | 33.17B | B | ||
+8.54% | 18.7B | C+ | ||
+22.10% | 11.28B | B+ | ||
+29.48% | 10.07B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HDFCLIFE Stock
- HDFCLIFE Stock
- Ratings HDFC Life Insurance Company Limited